CRISPR immunity: a case study for justified somatic genetic modification?
J Med Ethics
; 48(2): 83-85, 2022 02.
Article
en En
| MEDLINE
| ID: mdl-33658335
ABSTRACT
The current SARS-CoV-2 pandemic has killed thousands across the world. SARS-CoV-2 is the latest but surely not the last such global pandemic we will face. The biomedical response to such pandemics includes treatment, vaccination, and so on. In this paper, though, we argue that it is time to consider an additional strategy the somatic (non-heritable) enhancement of human immunity. We argue for this approach and consider bioethics objections we believe can be overcome.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Repeticiones Palindrómicas Cortas Agrupadas y Regularmente Espaciadas
/
COVID-19
Límite:
Humans
Idioma:
En
Revista:
J Med Ethics
Año:
2022
Tipo del documento:
Article
País de afiliación:
Estados Unidos